Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Disorders of the Male Reproductive System01:20

Disorders of the Male Reproductive System

Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra. Symptoms...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prevention and management of syphilis in pregnant and perinatal women.

Infectious diseases nowยท2025
Same author

Mental well-being in prostate cancer: A multi-institutional prospective cohort study.

BJUI compassยท2025
Same author

The diagnostic value of MRI for persistent prostate cancer following irreversible electroporation focal therapy.

BJU internationalยท2025
Same author

Syphilis testing in blood donors, France, 2007 to 2022.

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletinยท2024
Same author

Quality in clinical research: an observational study of randomisation techniques in urological and general surgical studies.

International journal of surgery (London, England)ยท2024
Same author

Investigating the risk factors of penile arterial insufficiency and veno-occlusive dysfunction in patients with erectile dysfunction.

BJUI compassยท2024
Same journal

Flat magnetic stimulation treatment for urinary incontinence: analysis and six months follow-up of 180 cases.

Archivio italiano di urologia, andrologia : organo ufficiale [di] Societa italiana di ecografia urologica e nefrologicaยท2026
Same journal

Management of complex pelvic fracture urethral injury following high-energy trauma in female patients: a case series.

Archivio italiano di urologia, andrologia : organo ufficiale [di] Societa italiana di ecografia urologica e nefrologicaยท2026
Same journal

Renal suppurative infections: analysis of a series of 32 cases.

Archivio italiano di urologia, andrologia : organo ufficiale [di] Societa italiana di ecografia urologica e nefrologicaยท2026
Same journal

Safety and efficacy of navigable suction-assisted ureteral access sheath for treatment of kidney stones.

Archivio italiano di urologia, andrologia : organo ufficiale [di] Societa italiana di ecografia urologica e nefrologicaยท2026
Same journal

Diagnostic performance of PI-RADS and PSA density for detecting clinically significant prostate cancer.

Archivio italiano di urologia, andrologia : organo ufficiale [di] Societa italiana di ecografia urologica e nefrologicaยท2026
Same journal

The relationship of prostate cancer diagnosed by magnetic resonance imaging/transrectal ultrasound prostate fusion biopsy with standard and adjusted anogenital distances.

Archivio italiano di urologia, andrologia : organo ufficiale [di] Societa italiana di ecografia urologica e nefrologicaยท2026
See all related articles

Related Experiment Video

Updated: Jun 11, 2026

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer
13:19

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer

Published on: November 2, 2013

Prostate specific antigen through the years.

Chryssanthos Kouriefs1, Mukhtar Sahoyl, Philippe Grange

  • 1Department of Urology, Kings College Hospital, Denmark Hill, London, United Kingdom. ckouriefs@hotmail.com

Archivio Italiano Di Urologia, Andrologia : Organo Ufficiale [Di] Societa Italiana Di Ecografia Urologica E Nefrologica
|July 9, 2010
PubMed
Summary
This summary is machine-generated.

Prostate-Specific Antigen (PSA) has been used since 1986 to manage prostate cancer. Its role in screening remains unclear, with ongoing trials and emerging markers like PCA3 showing promise.

More Related Videos

A Murine Orthotopic Bladder Tumor Model and Tumor Detection System
06:23

A Murine Orthotopic Bladder Tumor Model and Tumor Detection System

Published on: January 12, 2017

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent
06:54

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent

Published on: September 3, 2013

Related Experiment Videos

Last Updated: Jun 11, 2026

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer
13:19

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer

Published on: November 2, 2013

A Murine Orthotopic Bladder Tumor Model and Tumor Detection System
06:23

A Murine Orthotopic Bladder Tumor Model and Tumor Detection System

Published on: January 12, 2017

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent
06:54

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent

Published on: September 3, 2013

Area of Science:

  • Urology
  • Oncology
  • Biochemistry

Background:

  • Prostate-Specific Antigen (PSA) was identified in the 1960s, with simultaneous discovery by different research groups.
  • PSA was FDA-approved in 1986 for managing prostate cancer and in 1994 as a diagnostic tool.

Observation:

  • The utility of PSA as a screening test for prostate cancer is not fully established.
  • Clinical trial results from PLCO and ERSPC are pending, which may clarify PSA's screening role.
  • Emerging research explores PSA's potential in managing Benign Prostatic Hyperplasia (BPH).

Findings:

  • While PSA is established, its role in screening requires further validation.
  • Novel biomarkers, including EPCA, prostasomes, and PCA3, are under investigation for prostate cancer diagnostics.
  • Maturing data on PCA3 suggests its potential as a diagnostic tool for prostate cancer.

Implications:

  • Further research and clinical trials are needed to define the optimal use of PSA in prostate cancer screening and management.
  • Emerging biomarkers may offer improved diagnostic accuracy and personalized treatment strategies for prostate cancer.
  • Understanding the evolving landscape of prostate cancer biomarkers is crucial for clinical practice and patient outcomes.